IDAHO TO HOST MEMORY AND COMPUTE BREAKTHROUGHS
Over the next decade, Micron Technologies is looking to invest $10 billion to scale collaboration between government, industry, startups and academia in pursuit of memory and compute breakthroughs. This initiative will take place within the upcoming Micron Research Labs, a new institution to be located at the company’s campus in Boise, Idaho. Micron Research Labs marks the first dedicated memory research hub in the country, pulling together key players within the semiconductor ecosystem to explore research areas including critical memory technologies, advanced memory and computer architectures, packaging and future semiconductor manufacturing. The multibillion-dollar investment will support new university collaborations, global satellite labs and deep ecosystem partnerships, according to Micron’s press release. The company aims to break ground on the research institute in 2027. “This builds on the more than $250 billion we have separately committed to manufacturing and R&D across the United States, because as the only U.S.-based manufacturer of memory,” said Micron Technology President and CEO Sanjay Mehrotra, “we have long believed in the future that AI is now making real.”
Getty Images
A SWIFT TRANSFER INTO THE EUROPEAN MARKET
Within Lithuania’s capital city of Vilnius, a global fintech company providing money transfer services primarily to the global diaspora of non-resident Indians plans to establish a new European Union base. This move represents Aspora’s first regulated presence in the European market upon receiving approval to acquire a Lithuanian-licensed electronic money institution. The license will enable the Aspora, formerly operating as Vance prior to 2021, to connect its leadership to Lithuania’s business ecosystem and strengthen remittance along the EU-to-India corridor. “Lithuania offered exactly what we needed in an EU base,” said Aspora CEO Nedas Sipovičius. “A deep pool of fintech, engineering and compliance talent, and in the Bank of Lithuania a highly regarded and experienced regulator.” Once operational, the company plans to create 100 new jobs over the next three years.
Getty Images
GENENTECH EXPANDS A CRITICAL U.S. MANUFACTURING HUB
Leading biotech company Genentech has announced a new $750 million investment to expand its base in Hillsboro, Oregon. The company plans to construct a device fill-finish manufacturing plant at its 20-year-old, 75-acre campus in the region, delivering fresh end-to-end device filling capabilities to its operations. This news follows the company’s increased investment in Holly Springs, North Carolina, which scaled to $2 billion in January 2026. The new Hillsboro facility will focus on advanced drug delivery devices, including pre-filled syringes and autoinjectors, and will be capable of handling high and low-volume device filling across its product portfolio. Genentech’s latest addition will aid in securing a domestic supply chain across therapeutic areas like oncology, immunology and neurology. “Thanks to its skilled workforce and strong community, Hillsboro remains vital to our U.S. operations,” said Genentech CEO Ashley Magargee. “By adding end-to-end filling capabilities, this expansion deepens our commitment to manufacturing in the U.S. and gives us the flexibility to support a growing pipeline.”
Reports compiled and written by Alexis Elmore
